A top U.S. health official on Monday called for the combined measles-mumps-rubella shot to be broken up, drawing a quick rebuke from vaccine maker Merck, which said there is no scientific evidence ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
Pfizer is looking to newer products and acquisitions to offset a declining Covid business.
The decisions by Pfizer and Merck to share their COVID-19 drug patents stands in stark contrast to the refusal of Pfizer and other vaccine-makers to release their vaccine recipes ...
The updated 2024-2025 mRNA COVID vaccine from Moderna does not appear to carry the same risk for myocarditis in young adults that the first mRNA COVID vaccines did, suggested research presented at the ...
This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. The Food and Drug Administration ...
AstraZeneca is to start clinical trials to test a combination of its experimental coronavirus vaccine with Russia's Sputnik V shot to see if this can boost the efficacy of the British drugmaker's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results